Increasing COVID-19, Influenza, and Pneumonia Vaccine Uptake
Improving Vaccine Acceptance and Uptake Among Underresourced African American and Latinx Older Adults: A Multidisciplinary and Culturally Based Training Program for Minority Churches
| Sponsors |
Lead Sponsor: Charles Drew University of Medicine and Science |
||||||||
|---|---|---|---|---|---|---|---|---|---|
| Source | Charles Drew University of Medicine and Science | ||||||||
| Brief Summary | This proposed study seeks to community knowledge and understand the experience of underserved communities in the exploration of reducing health disparities and increasing vaccine uptake and acceptability COVID-19, influenza, and pneumonia for AA and Latinx populations. Unique in its design, it has the following characteristics: 1) multifaceted, 2) culturally tailored, 3) community-based, and 4) mixed methods in which the outcomes of interest will be measured before and after the intervention with 18-month interval. Furthermore, we seek to enhance our partnerships and collaborations with churches in South Los Angeles by supporting efforts to encourage COVID-19, influenza, and pneumonia vaccination uptake among underserved minorities in one of the most challenged and hard-to-reach population areas in the nation. |
||||||||
| Detailed Description | This study seeks to augment community knowledge and increase vaccine uptake among under-resourced African American and Latinx communities in South LA via leveraging trusted church leaders, educators and influencers to delivering COVID-19, influenza, and pneumonia education on vaccination. Unique in its design, this study has the following characteristics, beneficial to the acceptability and success of the proposal, it is: 1) multifaceted, 2) culturally tailored, and 3) community-based, in which the outcomes of interest will be compared longitudinally between arms 1-3, including measurement before and after the intervention with 9- and 18-month interval. |
||||||||
| Overall Status | Not yet recruiting | ||||||||
| Start Date | October 1, 2021 | ||||||||
| Completion Date | December 31, 2026 | ||||||||
| Primary Completion Date | October 31, 2026 | ||||||||
| Phase | N/A | ||||||||
| Study Type | Interventional | ||||||||
| Primary Outcome |
|
||||||||
| Secondary Outcome |
|
||||||||
| Enrollment | 570 | ||||||||
| Condition | |||||||||
| Intervention |
Intervention Type: Behavioral Intervention Name: Full VEPMP Intervention Description: Delivery of intrapersonal/interpersonal (i.e., motivational interviewing, vaccine educators, personal testimony, etc.), AND organizational (i.e., church-based sponsored events, seminars, web/online activities, bulletin inserts, etc.) Arm Group Label: Arm 1 Intervention Type: Behavioral Intervention Name: Partial VEPMP Intervention Description: Delivery of iAND organizational (i.e., church-based sponsored events, seminars, web/online activities, bulletin inserts, etc.) Arm Group Label: Arm 2 Intervention Type: Behavioral Intervention Name: Delayed VEPMP Intervention Description: Delayed implementation of delivery of intrapersonal/interpersonal AND organizational after 1 year of study start Arm Group Label: Arm 3 |
||||||||
| Eligibility |
Criteria:
Inclusion Criteria: - Parishioner at a church receiving the VEPMP intervention - Identify as African American or Latinx, - at least 65 years and older - Have Not received a vaccine for COVID-19, influenza, or pneumonia within the previous 24 months - Agrees to study terms, which include follow-up interviews 9 and 18 months after study enrollment Exclusion Criteria: - Does not attend or identify as a Parishioner at a church receiving the VEPMP intervention - Does not identify as African American or Latinx - Under the age of 65 years - Received all vaccine doses for COVID-19, influenza, or pneumonia within the previous 24 months Gender: All Minimum Age: 65 Years Maximum Age: N/A Healthy Volunteers: Accepts Healthy Volunteers |
||||||||
| Overall Official |
|
||||||||
| Overall Contact |
Last Name: Mohsen Bazargan, PhD Phone: 3233573655 Email: [email protected] |
||||||||
| Location |
|
||||||||
| Location Countries |
United States |
||||||||
| Verification Date |
February 2021 |
||||||||
| Responsible Party |
Type: Sponsor |
||||||||
| Keywords | |||||||||
| Has Expanded Access | No | ||||||||
| Condition Browse | |||||||||
| Number Of Arms | 3 | ||||||||
| Arm Group |
Label: Arm 1 Type: Experimental Description: This arm will include 5 churches who will receive all study activities in the Vaccine Education Promotion Management Plan Label: Arm 2 Type: Experimental Description: This arm will include 5 churches who will receive some study activities in the Vaccine Education Promotion Management Plan Label: Arm 3 Type: Experimental Description: This arm will include 5 churches who will receive all study activities in the Vaccine Education Promotion Management Plan following completion of Arm 1 and 2. |
||||||||
| Patient Data | No | ||||||||
| Study Design Info |
Allocation: Randomized Intervention Model: Parallel Assignment Intervention Model Description: The VEPMP will consist of recruited churches in 15 cohorts of 2 churches per cohort (total n = 30). Each cohort of church will include an AA and a Latinx church. The 15 church cohorts will be randomized to three arms based on a 1:1:1 ratio, using an online random number generator. Primary Purpose: Health Services Research Masking: None (Open Label) |
||||||||